Cargando…

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma

Multiple myeloma (MM) has one of the highest risks of venous thromboembolism (VTE) of all cancers due to pathologic changes and treatment-related exposures. This study assessed the one-year incidence of VTE in newly diagnosed MM and to determine the baseline and time-varying treatment-related factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Joshua D., Adams, Val R., Moga, Daniela C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198135/ https://www.ncbi.nlm.nih.gov/pubmed/27999418 http://dx.doi.org/10.3390/healthcare4040093

Ejemplares similares

Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies
por: Brown, Joshua D., et al.
Publicado: (2016)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
por: Barrett, Aisling, et al.
Publicado: (2021)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma
por: Yang, Bianhong, et al.
Publicado: (2023)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
por: Baker, Hailey A., et al.
Publicado: (2018)

Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
por: Brown, Joshua D., et al.
Publicado: (2018)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management
por: George, Anil P., et al.
Publicado: (2019)

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
por: Cornell, Robert Frank, et al.
Publicado: (2019)

Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
por: Baz, Rachid, et al.
Publicado: (2020)

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase
por: Awada, Hussein, et al.
Publicado: (2023)

Venous ligation versus venous repair: does the procedure impact venous thromboembolism risk?
por: Farrell, Michael Steven, et al.
Publicado: (2021)

Lower risk of venous thromboembolism in multiple Asian ethnic groups
por: Nicole Tran, H., et al.
Publicado: (2019)

Risk impact of edoxaban in the management of stroke and venous thromboembolism
por: Hurst, Katherine V, et al.
Publicado: (2016)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release
por: Gidaro, Antonio, et al.
Publicado: (2022)

The Impact of Central Venous Catheters on Pediatric Venous Thromboembolism
por: Jaffray, Julie, et al.
Publicado: (2017)

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
por: Huang, Duo, et al.
Publicado: (2019)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model
por: Ahmad, Abrar, et al.
Publicado: (2018)

Pharmacological cancer treatment and venous thromboembolism risk
por: Muñoz Martín, Andrés J, et al.
Publicado: (2020)

The emotional impact on patients of venous thromboembolism
por: Ribeiro, Alcides José Araújo, et al.
Publicado: (2023)

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism
por: Tellor, Katie B, et al.
Publicado: (2016)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Chen, Ying, et al.
Publicado: (2021)

Secondary Polycythemia and the Risk of Venous Thromboembolism
por: Bhatt, Vijaya Raj
Publicado: (2014)

Risk of Venous Thromboembolism in Glioblastoma Patients
por: Lim, Gerald, et al.
Publicado: (2018)

The Risk of Venous Thromboembolism in Patients with Gallstones
por: Chen, Chien-Hua, et al.
Publicado: (2020)

Venous Thromboembolism Risk Score and Pregnancy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status
por: Roubinian, Nareg H., et al.
Publicado: (2022)

Transitions in the Prophylaxis, Treatment and Care of Patients with Venous Thromboembolism
por: Lenchus, Joshua D.
Publicado: (2015)

The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients
por: Gross, Cary P., et al.
Publicado: (2007)

Evaluation of the impact of body mass index on venous thromboembolism risk factors
por: Tajik, Fatemeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_emldqcdci5u1ar64hh2hp8edvm